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Background. Genetic inﬂuences contribute signiﬁcantly to co-morbidity between conduct disorder and substance use
disorders. Estimating the extent of overlap can assist in the development of phenotypes for genomic analyses.
Method. Multivariate quantitative genetic analyses were conducted using data from 9577 individuals, including 3982
complete twin pairs and 1613 individuals whose co-twin was not interviewed (aged 24–37 years) from two
Australian twin samples. Analyses examined the genetic correlation between alcohol dependence, nicotine dependence
and cannabis abuse/dependence and the extent to which the correlations were attributable to genetic inﬂuences shared
with conduct disorder.
Results. Additive genetic (a2 = 0.48–0.65) and non-shared environmental factors explained variance in substance use dis-
orders. Familial effects on conduct disorder were due to additive genetic (a2 = 0.39) and shared environmental (c2 = 0.15)
factors. All substance use disorders were inﬂuenced by shared genetic factors (rg = 0.38–0.56), with all genetic overlap
between substances attributable to genetic inﬂuences shared with conduct disorder. Genes inﬂuencing individual sub-
stance use disorders were also signiﬁcant, explaining 40–73% of the genetic variance per substance.
Conclusions. Among substance users in this sample, the well-documented clinical co-morbidity between conduct dis-
order and substance use disorders is primarily attributable to shared genetic liability. Interventions targeted at generally
reducing deviant behaviors may address the risk posed by this shared genetic liability. However, there is also evidence
for genetic and environmental inﬂuences speciﬁc to each substance. The identiﬁcation of these substance-speciﬁc risk
factors (as well as potential protective factors) is critical to the future development of targeted treatment protocols.
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Introduction
There is substantial evidence that similar genetic fac-
tors inﬂuence liability to multiple substance use disor-
ders (e.g. Kendler et al. 2003a, 2007; Rhee et al. 2006;
Young et al. 2006; Xian et al. 2008; Sartor et al. 2010;
Palmer et al. 2013). Most notably, Kendler et al. (2007)
identiﬁed two genetic factors, corresponding to the co-
variance across licit (alcohol, nicotine, caffeine) and il-
licit (cannabis, cocaine) drugs; however, the genetic
factors were highly correlated (r = 0.82). Conduct dis-
order has been repeatedly implicated as a co-morbid
feature of substance use disorders and there is substan-
tial evidence that genetic inﬂuences contribute to this
co-morbidity. For instance, another study by Kendler
and colleagues found that alcohol and drug depend-
ence shared a sizeable proportion of their genetic liabil-
ity with conduct and antisocial personality disorder,
and less so with internalizing disorders, such as de-
pression (Kendler et al. 2003b). Button and colleagues
(2006) also found signiﬁcant genetic overlap between
conduct disorder and both alcohol and illicit drug de-
pendence in an adolescent sample, and that residual
genetic overlap between alcohol and illicit drug de-
pendence, after adjusting for conduct disorder, was
non-signiﬁcant. Similar results indicating the absence
of a residual genetic correlation between alcohol and
cannabis dependence when accounting for genetic
overlap with antisocial personality disorder have also
been noted in adult Vietnam era males (Fu et al.
2002). Other studies suggest that this shared liability
extends to additional aspects of externalizing behavior,
including novelty seeking and non-substance-related
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behavioral disinhibition (Krueger et al. 2002; Hicks
et al. 2011).
Based on this extant literature, it remains un-
answered the extent to which the genetic covariation
across the three most common forms of substance
use disorder (i.e. alcohol, nicotine and cannabis) is at-
tributable to genes shared with conduct disorder.
Two outcomes might be expected. One possibility is
that all the genetic inﬂuences on the three substances
are overlapping with each other and with conduct dis-
order, with limited evidence for substance-speciﬁc or
conduct disorder-speciﬁc genetic factors. This is un-
likely given prior evidence for signiﬁcant substance-
speciﬁc genetic inﬂuences on substance dependence
symptoms and on conduct disorder (Kendler et al.
2003b; Button et al. 2006, 2007). Alternatively, a moder-
ate to high genetic correlation across the three sub-
stances might be expected, with evidence for
substance-speciﬁc genes. Whether the entire propor-
tion of this genetic correlation is due to genes shared
with conduct disorder or whether some of this genetic
correlation is independent of it (i.e. shared across the
substances but not with conduct disorder) has not
been examined. This study of the extent to which the
genetics of conduct disorder contribute to genetic li-
ability to substance use disorders is critical to
gene-ﬁnding efforts where increasing sample sizes,
often capitalizing on differing deﬁnitions of pheno-
types with overlapping genetic underpinnings, is a ne-
cessity (Hicks et al. 2011). Equally important is the
estimation of substance-speciﬁc genetic inﬂuences.
For instance, Kendler et al. (2007) noted that substance-
speciﬁc genetic variance ranged from 3% for cocaine to
91% for caffeine abuse/dependence symptoms.
To examine this question, we utilized data from 9577
adult male and female twins aged 24–37 years drawn
from two samples derived from the Australian Twin
Registry. Speciﬁcally we ﬁt a quadrivariate model
that examined the extent to which genetic and environ-
mental inﬂuences were shared across conduct disorder
and DSM-IV diagnoses of nicotine dependence (ND)
and alcohol dependence (AD), and a modiﬁed canna-
bis abuse/dependence (CAD) diagnosis based on a
subset of DSM-IV criteria.
Method and materials
Sample
Twin pairs from two cohorts of the volunteer
Australian Twin Registry were included in the present
analyses (Maciejewski et al. 2014). As described in de-
tail elsewhere, telephone diagnostic interviews were
completed for one cohort in 1996–2000 (see Knopik
et al. 2004 for details) and for the other in 2005–2009
(Lynskey et al. 2012). The samples had comparable
ages at the time of interview (mean = 29.94 and mean =
31.85, respectively). After removing individuals of un-
known zygosity and those with no data for any of the
four outcomes, the sample for the present analyses
included 9577 individuals (6255 of 6257 interviewed
individuals in the ﬁrst cohort; 3322 of 3348 inter-
viewed individuals in the second cohort). The 3982
complete twin pairs included: 1096 monozygotic
(MZ, or identical) female twin pairs, 665 MZ male
pairs, 817 dizygotic (DZ, or fraternal) female pairs,
513 DZ male pairs, and 891 male–female twin pairs;
data from 1613 individuals without co-twin data,
which contribute to estimates of prevalence (but
not variance decomposition), were also included.
Zygosity was determined using standard items about
physical similarity which have been shown in a subset
of the present respondents to have 95% agreement
with DNA analysis (Medland et al. 2009). Verbal
informed consent was obtained from all participants,
and the procedures were approved by the Human
Research Protection Ofﬁce at Washington University
and the Human Research Ethics Committee at the
Queensland Institute of Medical Research.
Measures
Both cohorts completed a diagnostic telephone inter-
view based on the Semi-structured Assessment of
the Genetics of Alcoholism [Australian version,
SSAGA-OZ (Bucholz et al. 1994; Heath et al. 1997)],
which included DSM-IV (APA, 1994) assessments of
conduct disorder, and ND, AD, and CAD.
Conduct disorder
Respondents were asked about 15 behaviors associated
with DSM-IV conduct disorder (e.g. bullying, threaten-
ing, stealing, rule-breaking). Individuals who indicated
that 53 behaviors (without requiring impairment) oc-
curred within a 12-month period prior to age 18 years
were coded as having conduct disorder. None of the
items used in the conduct disorder section was related
to substance use or misuse.
Nicotine
Respondents who had smoked at least 100 cigarettes
lifetime or who had smoked 21–99 cigarettes and had
smoked for at least 52 days a week for 53 weeks,
completed a detailed DSM-IV nicotine dependence
(ND) assessment. Individuals who endorsed 53 de-
pendence symptoms (out of seven) within a
12-month period were coded as having a history of
ND. Because individuals who do not initiate using a
substance (i.e. never user) should be considered
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unmeasured for their liability to developing substance
use disorders (Neale et al. 2006), individuals who had
never tried cigarettes were coded as missing for ND
(n = 1001). Individuals with <3 dependence symptoms,
those whose symptoms did not cluster within a
12-month period, and individuals who had tried cigar-
ettes but had only experimented with nicotine (i.e. had
smoked <100 cigarettes lifetime and had not smoked
for at least 52 days per week, n = 3900) were coded
as unaffected for ND.
Alcohol
Respondents were asked about their lifetime alcohol
consumption. Individuals who had consumed at least
ﬁve drinks in a 24-h period at least once completed a
detailed DSM-IV alcohol dependence (AD) assessment
and were included in analyses of AD. Those indivi-
duals who endorsed 53 AD symptoms (out of
seven) within a 12-month period were coded as having
a history of AD. Non-drinkers (n = 105) and those who
had not consumed at least ﬁve drinks in a 24-h period
(n = 908) were coded as missing for AD analyses.
Cannabis
Individuals who had used cannabis511 times or who
had used cannabis at least monthly during the period
of heaviest use were asked questions tapping
DSM-IV cannabis abuse and dependence (CAD). The
ﬁrst cohort was only asked about two abuse symptoms
(hazardous use and role interference) and four depend-
ence symptoms (tolerance, using more than intended,
continued use despite emotional/psychological prob-
lems caused/exacerbated by use, and repeated desire
or inability to cut down on use). Although the second
cohort was asked additional abuse and dependence
questions, the present analyses used only the symp-
toms assessed in both cohorts. Respondents were iden-
tiﬁed as having CAD if they endorsed any abuse
symptom or they endorsed52 dependence symptoms
(symptoms were not required to have clustered within
a 12-month period). Because individuals who do not
initiate using a substance (i.e. never user) should be
considered unmeasured for their liability to develop-
ing substance use disorders (Neale et al. 2006), indivi-
duals who had never tried cannabis were coded as
missing for CAD (n = 3499). Individuals who com-
pleted the CAD section but did not meet the criteria
for CAD listed above as well as those who had min-
imal cannabis exposure (i.e. had tried cannabis but
used it <11 times and had not used it at least monthly
during their period of heaviest use; n = 3114) were
coded as unaffected for CAD.
Statistical analyses
Quantitative genetic analyses were used to estimate the
relative contributions of genetic and environmental
factors to outcomes, and the overlap between diagno-
ses. As detailed elsewhere (Neale & Cardon, 1992),
twin models allow for the estimation of additive genet-
ic factors (A), non-additive genetic factors (D), shared
environmental factors (C, environmental inﬂuences
that make twins similar to each other), and non-shared
environmental factors (E, environmental inﬂuences not
shared by twins, as well as error variance). Genetic
inﬂuences are indicated when the identical twin (MZ)
correlation is greater than the fraternal twin (DZ) cor-
relation. If all twin pair similarity were attributable to
A, the MZ correlation would be about twice the DZ
correlation, because MZ twins share all of their genes
and DZ twins share half of their segregating genes
(on average). D is indicated when the DZ correlation
is less than half the MZ correlation (because MZ
twins again share all non-additive inﬂuences but DZ
twins only share one quarter of such inﬂuences, on
average), and C is indicated when the DZ correlation
is more than half the MZ correlation. Models contain-
ing only twins reared together cannot estimate both
C and D simultaneously, and a decision as to which
should be estimated is made based on correlations be-
tween identical and fraternal twins.
A quadrivariate Cholesky (lower triangular) decom-
position was used to assess the degree of genetic and
environmental inﬂuence on each measure, as well as
the overlap across conduct disorder, ND, AD, and
CAD. A full Cholesky model allows for inﬂuences on
the ﬁrst variable to also load on all subsequent vari-
ables, and for novel inﬂuences on each subsequent
variable to load on all remaining variables. The E para-
meters in Fig. 1 show a full Cholesky parameterization,
and the comparable Cholesky parameterizations for
the familial components are shown in Supplementary
Fig. S1 [see also work by Neale and colleagues
(Neale & Cardon, 1992; Neale, 2004)]. Conduct dis-
order was entered into the Cholesky model ﬁrst.
Given that individuals become at risk for developing
dependence when they initiate substance use and
that not all users develop dependence, ordering of
the substance diagnosis variables in the Cholesky
model (ND, AD, CAD) was determined by the most
typical pattern of substance initiation. Of those who
had tried all three substances, 60.0% tried cigarettes be-
fore both alcohol and cannabis, and an additional
18.3% initiated multiple substances in the same year,
with cigarettes being one of those substances; 20.0%
initiated alcohol ﬁrst; 0.8% initiated cannabis ﬁrst. Of
individuals who had tried two of the three substances,
94.6% had used cigarettes and alcohol; 60.7% of those
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who had used two substances initiated cigarettes be-
fore alcohol, 21.1% initiated alcohol before cigarettes,
and 12.9% initiated cigarettes and alcohol within the
same year. This ordering of variables in the Cholesky
model (conduct disrder, ND, AD, CAD) was also sup-
ported by the mean ages of initiation (see Table 1).
The ﬁt of the full Cholesky model was compared to a
saturated model, which allowed us to test whether the
assumptions of twin modeling were met. Sub-models
dropping speciﬁc paths were used to test the signiﬁcance
of familial inﬂuences, and theoverlap in inﬂuences across
measures. To minimize the large number of tests that
would need to be conducted to examine combinations
of paths that could be dropped from themodel, omnibus
tests that constrained a family of paths were ﬁrst ﬁt to the
data in amanner that ﬁt with the correlation patterns and
with conceptually meaningful tests (single-parameter
tests, presented in Supplementary Table S2, conﬁrmed
that no individual path in an omnibus test was statistic-
ally signiﬁcant). The signiﬁcance of paths was tested by
comparing the ﬁt of each sub-model to the preceding
model and calculating the difference in −2 times the
log-likelihood of the prior model and the sub-model,
which is interpreted as a χ2 test for the given degrees
of freedom (df). Models were ﬁtted using the statis-
tical package Mx (Neale, 2004) using full informa-
tion maximum-likelihood estimation with raw data.
Analyzing raw data in Mx (Neale, 2004) allowed us to
utilize data fromconduct disorder for everyone, and sub-
stance dependence data fromeach individual for the sub-
stances he/she had used more times than the cut-off
established. All quadrivariate models included gender
and cohort as covariates.
Ethical standards
The authors assert that all procedures contributing to
this work comply with the ethical standards of the rele-
vant national and institutional committees on human
experimentation and with the Helsinki Declaration of
1975, as revised in 2008.
Results
Demographic and substance use characteristics are
shown in Table 1. Alcohol initiation was endorsed by
Fig. 1. Final quadrivariate genetic model with standardized parameter estimates. Paths are only shown for one twin; paths
for the second twin are equated to the ﬁrst twin, and connected to each other by ﬁxed values in keeping with quantitative
genetic theory (1.0 for genetic paths between MZ twins; 0.5 for genetic paths between DZ twins; 1.0 for shared environmental
paths between MZ and DZ twins). Latent variables are indicated by circles; observed variables by rectangles. A, Additive
genetic inﬂuences; C, shared environmental inﬂuences; E, non-shared environmental inﬂuences. The subscript 1 indicates
factors inﬂuencing conduct disorder; 2 is additional factors for nicotine dependence; 3 is additional factors for alcohol
dependence; 4 is additional factors for cannabis abuse/dependence; A1 is a genetic factor common to all measures. Diagonal
lines indicate paths from one measure that load on other measures. Solid lines indicate signiﬁcant paths. Parameter estimates
can be squared to determine the proportion of variance in the observed construct attributable to that path.
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almost 99% of the respondents, with 89% of the sample
reporting having consumed at least ﬁve drinks in a
24-h period and 26% of those having consumed 55
drinks in a 24-h period reporting a lifetime history of
AD. Over 88% of respondents had tried cigarettes,
with 33% of initiators having a history of ND.
Cannabis initiation was endorsed by 63% of respon-
dents, with 28% of initiators having a history of
CAD. Mean age of onset of conduct disorder was
13.84 years, which predated the average age of initi-
ation for cigarettes (mean = 14.06), alcohol (mean =
15.83), and cannabis (mean = 18.50).
Because all univariate genetic analyses indicated that
the parameter estimates could be equated for men and
women [Δχ2(3) range: 2.30–6.38, all p > 0.05], quadri-
variate analyses were collapsed across gender and gen-
der was included as a covariate (see Supplementary
Table S1 for the correlations for all ﬁve zygosity
groups). MZ and DZ twin-pair correlations, tested
using SAS software version 9.2 (SAS Institute Inc.,
2002–2008), indicated signiﬁcant familiality for all
measures (see Table 2). Univariate genetic models
conﬁrmed that additive genetic inﬂuences and non-
shared environmental inﬂuences were signiﬁcant for
all measures, with shared environmental inﬂuences
not reaching signiﬁcance for any measure, but reaching
p = 0.06 for conduct disorder (see Table 2).
A saturated model was used to estimate the tetra-
choric correlations in Mx (Neale, 2004), and served as
a baseline from which to test the assumptions of the
genetic models (−2 times the log-likelihood = 31
827.135 with 72 estimated parameters). The initial
genetic model, which included additive genetic, shared
environmental, and non-shared environmental paths
in a Cholesky parameterization, indicated that the
Cholesky parameterization was reasonable for the cur-
rent data (Δχ2 = 19.023, Δdf = 30, p = 0.94 compared to
the saturated model). Given that the correlation pattern
suggested genetic inﬂuence on all measures, with
smaller and less consistent evidence for shared envir-
onmental inﬂuences, we ﬁrst tested the signiﬁcance
of the shared environmental paths on and from ND
and AD. Eliminating all shared environmental
inﬂuences on and from ND (c21, c22, c32, and c42
in Supplementary Fig. S1) and AD (c31, c33, and c43
in Supplementary Fig. S1) resulted in a more parsi-
monious model without a signiﬁcant decrement in
ﬁt (total Δχ2 = 5.948, Δdf = 7, p = 0.55; also see
Supplementary Table S2 for the single-parameter
tests of change in model-ﬁt for this and all additional
tests). A test of the overlap in shared environmental
inﬂuences on conduct disorder and CAD indicated
that the overlap was not signiﬁcant (path c41 in
Supplementary Fig. S1; Δχ2 =−2.656, Δdf = 1, p > 0.99).
A sub-model specifying that all genetic overlap be-
tween the substances could be explained by genetic
inﬂuences shared with conduct disorder ﬁt the data
well (i.e. deleting paths a43, a42, and a32 from
Supplementary Fig. S1; Δχ2 = 0.664, Δdf = 3, p = 0.88;
also see Supplementary Table S2). From this model,
conﬁdence intervals and further model testing
conﬁrmed that it was possible to delete the remaining
CAD-speciﬁc shared environmental path (path c44 in
Supplementary Fig. S1; Δχ2 = 2.481, Δdf = 1, p = 0.12),
Table 1. Demographic and substance use characteristics of 9577
members of Australian twin pairs aged 24–37 years
Years, mean (S.D.)
Mean age at interview 30.60 (2.6)
Mean age at conduct disorder onset 13.84 (2.4)
Mean age at cigarette initiation 14.06 (3.4)
Mean age at nicotine dependence onset 21.96 (4.1)
Mean age at alcohol initiation 15.83 (2.6)
Mean age at alcohol dependence onset 21.87 (3.9)
Mean age at cannabis initiation 18.50 (3.4)
Mean age at cannabis dependence onseta 21.36 (3.9)
No. (%)
Male 3972 (41.5)
Monozygotic 4102 (42.8)
DSM-IV conduct disorder 1100 (11.6)
Nicotine use and dependence
Ever smoked a cigarette 8470 (88.5)
DSM-IV nicotine dependence
Population prevalence 2770 (28.9)
Of ever smokers 2770 (32.7)
Alcohol use and dependence
Ever had a full drink of alcohol 9456 (98.9)
Ever had55 drinks in a 24-h period 8544 (89.2)
DSM-IV alcohol dependence
Population prevalence 2219 (23.2)
Of those having consumed at least 5
drinks in a 24 h period
2219 (26.0)
Cannabis use and abuse/dependence
Ever used cannabis 6017 (63.2)
Cannabis abuse/dependence (modiﬁed DSM-IV)
Population prevalence 1683 (17.7)
Of ever users 1683 (28.0)
Data from n = 9577 individuals; n = 9501 individuals for
conduct disorder, n = 8470 for nicotine dependence, 8544 for
alcohol dependence, and n = 6017 for cannabis abuse/
dependence.
a Age at clustering for n = 311 individuals in the second
cohort who met the modiﬁed DSM-IV cannabis abuse/
dependence diagnosis (CAD). The n = 1683 with CAD
included n = 1122 from the ﬁrst cohort (age at diagnosis not
assessed); of the n = 561 cohort 2 individuals with the
modiﬁed CAD diagnosis, age was not assessed for the n =
177 with abuse only or the n = 73 with the modiﬁed 52
symptom dependence diagnosis but not the full DSM-IV
dependence diagnosis with 53 symptoms and clustering.
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but that all remaining genetic inﬂuences were statistic-
ally signiﬁcant, as indicated by a signiﬁcant decrement
in ﬁt when any path was deleted (Δχ2 range: 20.093–
262.394 with 1 df, all p < 0.001). Although modest in
magnitude, non-shared environmental inﬂuences over-
lapped across measures, with 5 of 6 paths being statis-
tically signiﬁcant (Δχ2 range: 5.846–28.275 with 1 df, all
p < 0.005; the non-shared environmental path from con-
duct disorder to ND, which could be dropped without
a signiﬁcant decrement in ﬁt (Δχ2 = 0.169 with 1 df, all
p = 0.68), was retained in the ﬁnal model but is indi-
cated by the dashed line in Fig. 1). The signiﬁcance
of the three substance-to-substance non-shared envir-
onmental parameters (e32, e42, and e43 from
Supplementary Fig. S1; also see Supplementary
Table S2) indicates that individual-speciﬁc effects
were shared across substances independent of the
effects each substance shared with conduct disorder.
The standardized parameter estimates from the
best-ﬁtting model are shown in Fig. 1, with the propor-
tions of variance presented in Table 3 and the genetic
and environmental correlations in Table 4. As shown
in Table 3, familial inﬂuences accounted for substantial
variance in all measures, with genetic factors explain-
ing 39% of the variance in conduct disorder, and
62%, 48%, and 65% of the variance in ND, AD, and
CAD, respectively. Shared environmental inﬂuences
accounted for an additional 15% of the variance in con-
duct disorder. Genetic correlations were signiﬁcant
and moderate to substantial (ranging from 0.38–0.77;
above the diagonal in Table 4), especially between con-
duct disorder and ND and CAD, where over 50% of
the genetic inﬂuences were overlapping. Importantly,
the genetic correlation across substances was entirely
attributable to genes shared with conduct disorder.
Non-shared environmental inﬂuences were predomin-
antly measure speciﬁc, as shown by the modest cor-
relations between individual-speciﬁc environmental
factors (range: 0.03–0.28; below the diagonal in
Table 4).
Discussion
In a large cohort of adult Australian twins, we show
that the previously well-documented shared genetic
etiology across ND, AD, and CAD was entirely attrib-
utable to genes contributed by a shared liability to con-
duct disorder. Our study extends previous research in
that we: (a) examined conduct disorder, ND, AD, and
CAD simultaneously in an adult sample [researchers
have examined these substances together (Kendler
et al. 2007, 2008), and have examined conduct disorder
Table 2. Twin-pair correlations and ﬁnal univariate genetic models (and 95% conﬁdence intervals) for conduct disorder, nicotine dependence,
alcohol dependence, and cannabis abuse/dependence
rMZ rDZ A C E
Conduct disorder 0.55* (0.46–0.64) 0.39* (0.30–0.48) 0.32* (0.05–0.59) 0.20a (0.00–0.41) 0.48* (0.38–0.58)
Nicotine dependence 0.63* (0.56–0.69) 0.31* (0.24–0.38) 0.62* (0.57–0.68) – 0.38* (0.32–0.44)
Alcohol dependence 0.51* (0.43–0.59) 0.22* (0.14–0.30) 0.47* (0.40–0.54) – 0.53* (0.46–0.60)
Cannabisabuse/dependence 0.63* (0.55–0.71) 0.40* (0.30–0.49) 0.63* (0.56–0.70) – 0.37* (0.30–0.44)
A, Additive genetic inﬂuences; C, shared environmental inﬂuences; E, non-shared environmental inﬂuences.
Data from n = 9501 individuals for conduct disorder, n = 8470 for nicotine dependence, n = 8544 for alcohol dependence, and
n = 6017 for cannabis abuse/dependence.
*Signiﬁcant at p < 0.05;
a Δχ2 = 3.59 when removed from the model, p = 0.06.
Table 3. Standardized proportions of variance (95% conﬁdence intervals) attributable to additive genetic, shared environmental, and
non-shared environmental inﬂuences in the best-ﬁtting quadrivariate model examining the genetic and environmental contributions to the
co-morbidity between conduct disorder, nicotine dependence, alcohol dependence, and cannabis abuse/dependence in 9577 Australian twins
Additive genetic Shared environment Non-shared environment
Conduct disorder 0.39 (0.31–0.48) 0.15 (0.07–0.22) 0.46 (0.39–0.53)
Nicotine dependence 0.62 (0.56–0.67) – 0.38 (0.34–0.44)
Alcohol dependence 0.48 (0.41–0.55) – 0.52 (0.45–0.59)
Cannabis abuse/dependence 0.65 (0.58–0.71) – 0.35 (0.29–0.43)
All variance components signiﬁcant at p < 0.05.
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with AD and general substance use disorders (Krueger
et al. 2002; Kendler et al. 2003b), but not all in the same
analysis]; (b) extended Hicks and colleagues analysis of
adolescents (aged 16–19 years; Hicks et al. 2011), which
could yield different patterns of overlap; (c) set to miss-
ing the data from individuals who had not initiated a
substance and hence had unknown genetic liability.
Our results are consistent with previous reports (Fu
et al. 2002; Kendler et al. 2003b; Button et al. 2006;
Hicks et al. 2011) showing that alcohol and drug de-
pendence tend to share an appreciable proportion of
their genetic liability with conduct and antisocial per-
sonality disorder, and further demonstrating that simi-
lar effects extend to ND and to substance use disorders
contingent on initiation. The overall structure of genet-
ic overlap (see Fig. 1) is also broadly consistent with
numerous twin studies of adolescent and adult popu-
lations indexing a general liability factor underlying a
host of externalizing disorders, including conduct dis-
order, substance use disorders and also impulsivity
and non-substance-related disinhibition (Krueger
et al. 2002; Hicks et al. 2011).
Such results have key implications for gene-ﬁnding
efforts such as genome-wide association studies
(GWAS). In particular, they imply that, as least when
examining initiators, phenotypes that aggregate across
various substance use disorders (e.g. Wetherill et al.
2015) or examine genetic variants that inﬂuence mul-
tiple substances (McGue et al. 2013; Vrieze et al. 2014)
may effectively be capturing genetic variation shared
with liability to conduct disorder. Thus, approaches
of aggregating across substances or of using conduct
disorder and other aspects of behavioral disinhibition
as proxies may be particularly useful in increasing
power to detect genetic variants shared across sub-
stances, particularly in adolescent cohorts where sub-
jects may not have fully passed through the period of
greatest risk for onset of substance use disorders
(Iacono et al. 1999; Rose et al. 2004; Button et al. 2006;
Hicks et al. 2011). However, at least one study reports
that polygenic scores created for individual
substance-related measures and behavioral disinhib-
ition are only modestly (r = 0.03–0.07) correlated with
each other (Vrieze et al. 2013).
Developmental changes in the degree to which gen-
etic factors contribute to substance involvement itself
also should be considered, although there is disagree-
ment about the pattern of change. For instance, re-
search by Vrieze et al. (2012) suggests that the genetic
contribution to the overlap across substances may de-
cline from adolescence into adulthood, while research
by Kendler and colleagues suggests that the genetic
contribution to overlap across substance use remains
steady, even increases modestly, across that time
span (Kendler et al. 2008). There is also evidence that
the correlation between conduct disorder and sub-
stance involvement is more attributable to shared en-
vironmental factors during adolescence (Rose et al.
2004). Thus, our ﬁnding of strong genetic overlap
may be speciﬁc to the age of our cohort (young adults)
and may not generalize to other developmental
settings.
Despite genetic overlap, the statistically signiﬁcant
role of substance-speciﬁc genetic inﬂuences cannot be
ignored. In fact, a signiﬁcant proportion of the genetic
variance in ND (40%), AD (73%), and CAD (47%) was
substance-speciﬁc. The ﬁnding of substance-speciﬁc
genetic inﬂuences corroborates previous research,
although the relatively higher proportion of speciﬁc
genetic inﬂuences on AD v. ND is in contrast to one
prior study that found ND to be most signiﬁcantly
inﬂuenced by speciﬁc genetic factors (Kendler et al.
2007). The magnitude of these speciﬁc genetic factors
underscores that when studying the genomic under-
pinnings of individual substance use disorders, var-
iants are not exclusively expected to reﬂect a general
liability to conduct disorder or externalizing problems.
Most notably, for AD and ND, the most robustly vali-
dated single nucleotide polymorphisms identiﬁed via
GWAS have been substance speciﬁc. For alcohol,
Table 4. Genetic (above diagonal) and non-shared environmental correlationsa between conduct disorder, nicotine dependence, alcohol
dependence, and cannabis abuse/dependence from the best-ﬁtting model examining the genetic and environmental contributions to the
co-morbidity between conduct disorder, alcohol dependence, nicotine dependence and cannabis abuse/dependence in 9577 Australian twins
Conduct disorder Nicotine dependence Alcohol dependence Cannabis abuse/dependence
Conduct disorder – 0.77* (0.69–0.87 ) 0.52* (0.44–0.61) 0.72* (0.64–0.81)
Nicotine dependence 0.03 (−0.10 to 0.14) – 0.40* (0.33–0.48) 0.56* (0.48–0.64)
Alcohol dependence 0.28* (0.19 to 0.38) 0.27* (0.17–0.35) – 0.38* (0.31–0.45)
Cannabis abuse/dependence 0.17* (0.05 to 0.31) 0.18* (0.06–0.31) 0.28* (0.17–0.39) –
*Indicates p < 0.05.
a Genetic correlations are above the diagonal; non-shared environmental correlations are below the diagonal.
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rs1229984 in the alcohol dehydrogenase (ADH1B) gene
is associated with accelerated conversion of ethanol to
acetaldehyde, thus protecting against alcoholism via a
speciﬁc metabolic pathway (Thomasson et al. 1993).
This functional polymorphism has been identiﬁed at
genome-wide signiﬁcant levels in two independent
studies (Bierut et al. 2012; Gelernter et al. 2014). For to-
bacco smoking, a similar metabolic variant in the cyto-
chrome P450 A6 (CYP2A6) gene has been identiﬁed in
one large meta-analysis (Thorgeirsson et al. 2010).
However, the most widely replicated ﬁndings are for
tobacco smoking and rs16969968 in the cholinergic
nicotinic receptor α5 subunit (CHRNA5) (Liu et al.
2010; Thorgeirsson et al. 2010; Tobacco and Genetics
Consortium, 2010) and other variants in the family of
genes encoding nicotinic receptor subunits, which
have been repeatedly identiﬁed at genome-wide sign-
iﬁcant levels. It is worth noting that the large GWAS
meta-analyses of smoking that identiﬁed rs16969968
relied on nicotine consumption measures such as cigar-
ettes per day (not dependence) and primarily included
samples in which the co-morbid effects of conduct dis-
order are likely to be minimal. These substance-speciﬁc
ﬁndings have also arisen in a sample with a high de-
gree of drug-related co-morbidity (e.g. Rice et al.
2012) but in that study, when studying one substance,
diagnoses of other substance use disorders were
accounted for, thus likely reﬁning the ability to home
in on substance-speciﬁc results. Future studies may
also wish to control for conduct disorder to further en-
hance chances of identifying drug-speciﬁc variants.
Some limitations of the current study are worth not-
ing. First, this is a sample of adult Caucasian
Australians and ﬁndings may not generalize to other
ethnic groups. Second, in order to test for the role of
substance initiation on the genetic overlap with sub-
stance use disorder, we set to missing the substance-
speciﬁc data for individuals who had never tried a
given substance (conduct disorder was analyzed for
everyone, as was substance dependence data from
each individual for the substances he/she had used
more times than the cutoff established). An alternate
approach would have been to use two-stage twin mod-
els where the relationship between substance use and
use disorders is expressly modeled (e.g. Kendler et al.
1999; Heath et al. 2002). However, this would have
resulted in a 7-variable multivariate structure which
our sample was underpowered to support. Third, a
related caveat is that we included nicotine and canna-
bis experimenters as unaffected for dependence; an al-
ternative would have been to restrict the analyses to
those with more substantial exposure, as we did with
alcohol. It is possible that the genetic overlap of con-
duct disorder with ND and CAD might change with
a different substance use threshold (e.g. if conduct
disorder is associated more with the transition to ‘regu-
lar use’ than with the transition to ‘dependence’).
Fourth, the ordering of variables in our Cholesky
model reﬂects the most commonly reported order of
onset, but there are individuals who had a different
order of onset. Although our variance components
are applicable regardless of the order of onset, some
of the parameter estimates in the Cholesky model
would differ if a different variable order was used.
Fifth, there is some evidence that the genetic structure
of alcohol problems is not attributable to a single fac-
tor; in twin analyses examining the seven individual
symptoms of DSM-IV AD, Kendler et al. (2012) found
that the individual symptoms were best explained
using three distinct genetic factors. However, analyz-
ing the individual symptoms for AD, ND and CAD
was beyond the scope of our analysis. Sixth, our
CAD diagnoses included only a subset of DSM-IV
symptoms (1+ of two abuse symptoms or 2+ of four de-
pendence symptoms), which may have affected our
prevalence and/or heritability. This was done because
only this subset of items was included in the 1996–
2000 cohort assessment. However, Lynskey and collea-
gues (2002) have reported that a diagnosis of CAD
based on these six items reasonably approximates the
population prevalence and does not attenuate esti-
mates of heritability. Finally, all of our diagnoses are
drawn from adult retrospective reports which may
have been subject to recall bias.
In this era of big data, several efforts are underway
to mega- and meta-analyze genome-wide data for sub-
stance use disorders. Our study indicates that looking
across substances may provide a unique set of genetic
variants that relate to a general vulnerability to con-
duct problems (at least among substance initiators),
whereas co-varying for co-morbid conduct disorder
may isolate substance speciﬁc ﬁndings. Importantly,
our study documents the enormous value of twin stud-
ies in providing a paradigm for development of
substance-related phenotypes for gene-identiﬁcation
efforts.
Supplementary material
For supplementary material accompanying this paper
visit http://dx.doi.org/10.1017/S0033291715001518.
Acknowledgements
This study was supported by grant funding from the
National Institute on Drug Abuse (NIDA) grants
DA23668 (A.A.), DA32573 (A.A.), DA18267 (M.T.L.)
and T32DA007313 (L.F.) as well as from the National
Institute of Alcohol Abuse and Alcoholism (NIAAA)
including AA11998, AA07728 and AA13221 to A.C.
3512 J. D. Grant et al.
H.. Data collection for sample 2 was also facilitated
through access to the Australian Twin Registry, a na-
tional resource supported by an Enabling Grant (ID
628911) from the National Health & Medical
Research Council. Funding agencies did not participate
in design and conduct of the study; collection, manage-
ment, analysis, and interpretation of the data; and
preparation, review, or approval of the manuscript.
The authors thank the Australian Twin Registry and
the twins themselves for participating in this research.
Declaration of Interest
None.
References
APA (1994). Diagnostic and Statistical Manual of Mental Disorders.
American Psychiatric Association: Washington, DC.
Bierut LJ, Goate AM, Breslau N, Johnson EO, Bertelsen S,
Fox L, Agrawal A, Bucholz KK, Grucza R, Hesselbrock V,
Kramer J, Kuperman S, Nurnberger J, Porjesz B, Saccone
NL, Schuckit M, Tischﬁeld J, Wang JC, Foroud T, Rice JP,
Edenberg HJ (2012). ADH1B is associated with alcohol
dependence and alcohol consumption in populations of
European and African ancestry. Molecular Psychiatry 17,
445–450.
Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH,
Hesselbrock VM, Nurnberger Jr. JI, Reich T, Schmidt I,
Schuckit MA (1994). A new, semi-structured psychiatric
interview for use in genetic linkage studies: a report on the
reliability of the SSAGA. Journal of Studies on Alcohol 55,
149–158.
Button TM, Hewitt JK, Rhee SH, Young SE, Corley RP,
Stallings MC (2006). Examination of the causes of
covariation between conduct disorder symptoms and
vulnerability to drug dependence. Twin Research and Human
Genetics 9, 38–45.
Button TM, Rhee SH, Hewitt JK, Young SE, Corley RP,
Stallings MC (2007). The role of conduct disorder in
explaining the comorbidity between alcohol and illicit drug
dependence in adolescence. Drug and Alcohol Dependence 87,
46–53.
Fu Q, Heath AC, Bucholz KK, Nelson E, Goldberg J, Lyons
MJ, True WR, Jacob T, Tsuang MT, Eisen SA (2002).
Shared genetic risk of major depression, alcohol
dependence, and marijuana dependence: contribution of
antisocial personality disorder in men. Archives of General
Psychiatry 59, 1125–1132.
Gelernter J, Kranzler HR, Sherva R, Almasy L, Koesterer R,
Smith AH, Anton R, Preuss UW, Ridinger M, Rujescu D,
Wodarz N, Zill P, Zhao H, Farrer LA (2014). Genome-wide
association study of alcohol dependence: signiﬁcant
ﬁndings in African- and European-Americans including
novel risk loci. Molecular Psychiatry 19, 41–49.
Heath AC, Bucholz KK, Madden PAF, Dinwiddie SH,
Slutske WS, Bierut LJ, Statham DJ, Dunne MP, Whitﬁeld
JB, Martin NG (1997). Genetic and environmental
contributions to alcohol dependence risk in a national twin
sample: consistency of ﬁndings in women and men.
Psychological Medicine 27, 1381–1396.
Heath AC, Martin NG, Lynskey MT, Todorov AA, Madden
PAF (2002). Estimating two-stage models for genetic
inﬂuences on alcohol, tobacco or drug use initiation and
dependence vulnerability in twin and family data. Twin
Research 5, 113–124.
Hicks BM, Schalet BD, Malone SM, Iacono WG, McGue M
(2011). Psychometric and genetic architecture of substance
use disorder and behavioral disinhibition measures for
gene association studies. Behavior Genetics 41, 459–475.
Iacono WG, Carlson SR, Taylor J, Elkins IJ, McGue M (1999).
Behavioraldisinhibitionandthedevelopmentof substance-use
disorders: ﬁndings from the Minnesota Twin Family Study.
Development and Psychopathology 11, 869–900.
Kendler KS, Aggen SH, Prescott CA, Crabbe J, Neale MC
(2012). Evidence for multiple genetic factors underlying the
DSM-IV criteria for alcohol dependence. Molecular
Psychiatry 17, 1306–1315.
Kendler KS, Jacobson KC, Prescott CA, Neale MC (2003a).
Speciﬁcity of genetic and environmental risk factors for use
and abuse/dependence of cannabis, cocaine, hallucinogens,
sedatives, stimulants, and opiates in male twins. American
Journal of Psychiatry 160, 687–695.
Kendler KS, Myers J, Prescott CA (2007). Speciﬁcity of
genetic and environmental risk factors for symptoms of
cannabis, cocaine, alcohol, caffeine, and nicotine
dependence. Archives of General Psychiatry 64, 1313–1320.
Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO,
Prescott CA (1999). A population-based twin study in
women of smoking initiation and nicotine dependence.
Psychological Medicine 29, 299–308.
Kendler KS, Prescott CA, Myers J, Neale MC (2003b). The
structure of genetic and environmental risk factors for
common psychiatric and substance use disorders in men
and women. Archives of General Psychiatry 60, 929–937.
Kendler KS, Schmitt E, Aggen SH, Prescott CA (2008).
Genetic and environmental inﬂuences on alcohol, caffeine,
cannabis, and nicotine use from early adolescence to middle
adulthood. Archives of General Psychiatry 65, 674–682.
Knopik VS, Heath AC, Madden PAF, Bucholz KK, Slutske
WS, Nelson EC, Statham D, Whitﬁeld JB, Martin NG
(2004). Genetic effects on alcohol dependence risk: re-
evaluating the importance of psychiatric and other heritable
risk factors. Psychological Medicine 34, 1519–1530.
Krueger RF, Hicks BM, Patrick CJ, Carlson SR, Iacono WG,
McGue M (2002). Etiologic connections among substance
dependence, antisocial behavior, and personality: modeling
the externalizing spectrum. Journal of Abnormal Psychology
111, 411–424.
Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P,
Middleton L, Berrettini W, Knouff CW, Yuan X, Waeber
G, Vollenweider P, Preisig M, Wareham NJ, Zhao JH,
Loos RJF, Barroso I, Khaw KT, Grundy S, Barter P,
Mahley R, Kesaniemi A, McPherson R, Vincent JB,
Strauss J, Kennedy JL, Farmer A, McGufﬁn P, Day R,
Matthews K, Bakke P, Gulsvik A, Lucae S, Ising M,
Genetic overlap between conduct and substance use disorders 3513
Brueckl T, Horstmann S, Wichmann HE, Rawal R,
Dahmen N, Lamina C, Polasek O, Zgaga L, Huffman J,
Campbell S, Kooner J, Chambers JC, Burnett MS,
Devaney JM, Pichard AD, Kent KM, Satler L, Lindsay JM,
Waksman R, Epstein S, Wilson JF, Wild SH, Campbell H,
Vitart V, Reilly MP, Li M, Qu L, Wilensky R, Matthai W,
Hakonarson HH, Rader DJ, Franke A, Wittig M, Schafer
A, Uda M, Terracciano A, Xiao X, Busonero F, Scheet P,
Schlessinger D, St Clair D, Rujescu D, Abecasis GR,
Grabe HJ, Teumer A, Volzke H, Petersmann A, John U,
Rudan I, Hayward C, Wright AF, Kolcic I, Wright BJ,
Thompson JR, Balmforth AJ, Hall AS, Samani NJ,
Anderson CA, Ahmad T, Mathew CG, Parkes M, Satsangi
J, Caulﬁeld M, Munroe PB, Farrall M, Dominiczak A,
Worthington J, Thomson W, Eyre S, Barton A, The
Wellcome Trust Case Control Consortium, Mooser V,
Francks C, Marchini J (2010). Meta-analysis and
imputation reﬁnes the association of 15q25 with smoking
quantity. Nature Genetics 42, 436–440.
Lynskey MT, Agrawal A, Henders AK, Nelson EC, Madden
PAF, Martin NG (2012). An Australian twin study of
cannabis and other illicit drug use and misuse, and other
psychopathology. Twin Research and Human Genetics 15,
631–641.
Lynskey MT, Heath AC, Nelson EC, Bucholz KK, Madden
PAF, Slutske WS, Statham DJ, Martin NG (2002). Genetic
and environmental contributions to cannabis dependence
in a national young adult twin sample. Psychological
Medicine 32, 195–207.
Maciejewski DF, Creemers HE, Lynskey MT, Madden PAF,
Heath AC, Statham DJ, Martin NG, Verweij KJH (2014).
Overlapping genetic and environmental inﬂuences on
nonsuicidal self-injury and suicidal ideation: different
outcomes, same etiology? JAMA Psychiatry 71, 699–705.
McGue M, Zhang Y, Miller MB, Basu S, Vrieze S, Hicks B,
Malone S, Oetting WS, Iacono WG (2013). A genome-wide
association study of behavioral disinhibition. Behavior
Genetics 43, 363–373.
Medland SE, Nyholt DR, Painter JN, McEvoy BP, McRae
AF, Zhu G, Gordon SD, Ferreira MA, Wright MJ, Henders
AK, Campbell MJ, Duffy DL, Hansell NK, Macgregor S,
Slutske WS, Heath AC, Montgomery GW, Martin NG
(2009). Common variants in the trichohyalin gene are
associated with straight hair in Europeans. American Journal
of Human Genetics 85, 750–755.
Neale MC (2004). Statistical Modeling with Mx. Department of
Psychiatry, Box #980710: Richmond, VA 23298.
Neale MC, Cardon LR (1992). Methodology for Genetic Studies
of Twins and Families. Kluwer Academic Publishers: The
Netherlands.
Neale MC, Harvey E, Maes HH, Sullivan PF, Kendler KS
(2006). Extensions to the modeling of initiation and
progression: applications to substance use and abuse.
Behavior Genetics 36, 507–524.
Palmer RH, Young SE, Corley RP, Hopfer CJ, Stallings MC,
Hewitt JK (2013). Stability and change of genetic and
environmental effects on the common liability to alcohol,
tobacco, and cannabis DSM-IV dependence symptoms.
Behavior Genetics 43, 374–385.
Rhee SH, Hewitt JK, Young SE, Corley RP, Crowley TJ,
Neale MC, Stallings MC (2006). Comorbidity between
alcohol dependence and illicit drug dependence in
adolescents with antisocial behavior and matched controls.
Drug and Alcohol Dependence 84, 85–92.
Rice JP, Hartz SM, Agrawal A, Almasy L, Bennett S, Breslau
N, Bucholz KK, Doheny KF, Edenberg HJ, Goate AM,
Hesselbrock V, Howells WB, Johnson EO, Kramer J,
Krueger RF, Kuperman S, Laurie C, Manolio TA,
Neuman RJ, Nurnberger JI, Porjesz B, Pugh E, Ramos
EM, Saccone N, Saccone S, Schuckit M, Bierut LJ (2012).
CHRNB3 is more strongly associated with Fagerstrom test
for cigarette dependence-based nicotine dependence than
cigarettes per day: phenotype deﬁnition changes
genome-wide association studies results. Addiction 107,
2019–2028.
Rose RJ, Dick DM, Viken RJ, Pulkkinen L, Kaprio J (2004).
Genetic and environmental effects on conduct disorder and
alcohol dependence symptoms and their covariation at
age 14. Alcoholism, Clinical and Experimental Reearch 28,
1541–1548.
Sartor CE, Grant JD, Bucholz KK, Madden PAF, Heath AC,
Agrawal A,Whitﬁeld JB, StathamDJ,Martin NG, Lynskey
MT (2010). Common genetic contributions to alcohol and
cannabis use and dependence symptomatology. Alcoholism,
Clinical Experimental Research 34, 545–554.
SAS Institute, Inc (2002–2008). SAS User’s Guide, Version 9.2.
SAS Institute Inc: Cary, NC.
Thomasson HR, Crabb DW, Edenberg HJ, Li TK (1993).
Alcohol and aldehyde dehydrogenase polymorphisms and
alcoholism. Behavior Genetics 23, 131–136.
Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM,
Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S,
Gieger C, Rawal R, Mangino M, Prokopenko I, Magi R,
Keskitalo K, Gudjonsdottir IH, Gretarsdottir S,
Stefansson H, Thompson JR, Aulchenko YS, Nelis M,
Aben KK, den Heijer M, Dirksen A, Ashraf H, Soranzo N,
Valdes AM, Steves C, Uitterlinden AG, Hofman A,
Tonjes A, Kovacs P, Hottenga JJ, Willemsen G,
Vogelzangs N, Doring A, Dahmen N, Nitz B, Pergadia
ML, Saez B, De Diego V, Lezcano V, Garcia-Prats MD,
Ripatti S, Perola M, Kettunen J, Hartikainen AL, Pouta A,
Laitinen J, Isohanni M, Huei-Yi S, Allen M,
Krestyaninova M, Hall AS, Jones GT, van Rij AM,
Mueller T, Dieplinger B, Haltmayer M, Jonsson S,
Matthiasson SE, Oskarsson H, Tyrﬁngsson T, Kiemeney
LA, Mayordomo JI, Lindholt JS, Pedersen JH, Franklin
WA, Wolf H, Montgomery GW, Heath AC, Martin NG,
Madden PAF, Giegling I, Rujescu D, Jarvelin MR,
Salomaa V, Stumvoll M, Spector TD, Wichmann HE,
Metspalu A, Samani NJ, Penninx BW, Oostra BA,
Boomsma DI, Tiemeier H, van Duijn CM, Kaprio J,
Gulcher JR, The ENGAGE Consortium, McCarthy MI,
Peltonen L, Thorsteinsdottir U, Stefansson K (2010).
Sequence variants at CHRNB3-CHRNA6 and CYP2A6
affect smoking behavior. Nature Genetics 42, 448–453.
Tobacco and Genetics Consortium (2010). Genome-wide
meta-analyses identify multiple loci associated with
smoking behavior. Nature Genetics 42, 441–447.
3514 J. D. Grant et al.
Vrieze SI, Feng S, Miller MB, Hicks BM, Pankratz N,
Abecasis GR, Iacono WG, McGue M (2014). Rare
nonsynonymous exonic variants in addiction and
behavioral disinhibition. Biological Psychiatry 75, 783–789.
Vrieze SI, Hicks BM, Iacono WG, McGue M (2012).
Decline in genetic inﬂuence on the co-occurrence of
alcohol, marijuana, and nicotine dependence symptoms
from age 14 to 29. American Journal of Psychiatry 169,
1073–1081.
Vrieze SI, McGue M, Miller MB, Hicks BM, Iacono WG
(2013). Three mutually informative ways to understand the
genetic relationships among behavioral disinhibition,
alcohol use, drug use, nicotine use/dependence, and their
co-occurrence: twin biometry, GCTA, and genome-wide
scoring. Behavior Genetics 43, 97–107.
Wetherill L, Agrawal A, Kapoor M, Bertelsen S, Bierut LJ,
Brooks A, Dick D, Hesselbrock M, Hesselbrock V, Koller
DL, Le N, Nurnberger Jr. JI, Salvatore JE, Schuckit M,
Tischﬁeld JA, Wang JC, Xuei X, Edenberg HJ, Porjesz B,
Bucholz K, Goate AM, Foroud T (2015). Association of
substance dependence phenotypes in the COGA sample.
Addiction Biology 20, 617–627.
Xian H, Scherrer JF, Grant JD, Eisen SA, True WR, Jacob T,
Bucholz KK (2008). Genetic and environmental
contributions to nicotine, alcohol and cannabis dependence
in male twins. Addiction 103, 1391–1398.
Young SE, Rhee SH, Stallings MC, Corley RP, Hewitt JK
(2006). Genetic and environmental vulnerabilities
underlying adolescent substance use and problem
use: general or speciﬁc? Behavior Genetics 36, 603–615.
Genetic overlap between conduct and substance use disorders 3515
